Showing 61 - 80 results of 1,817 for search '(( 1 m decrease ) OR ( 10 ((we decrease) OR (((a decrease) OR (mean decrease)))) ))*', query time: 0.21s Refine Results
  1. 61

    Molecular properties prediction, anticancer and anti-inflammatory activities of some pyrimido[1,2-b]pyridazin-2-one derivatives by Zeiz, Ali

    Published 2023
    “…Introduction: The anticancer and anti-inflammatory activities of a novel series of eleven pyrimido[1,2-b]pyridazin-2-one analogues substituted at position 7 were assessed in the current study. …”
    Get full text
    Get full text
  2. 62
  3. 63

    Allergenicity of roasted peanuts treated with a non-human digestive protease by Yu, Jianmei

    Published 2015
    “…The in vitro IgE-binding capacity of treated peanut extracts was determined by a competitive inhibition ELISA using pooled plasma of 10 peanut allergic patients. …”
    Get full text
    Get full text
    Get full text
  4. 64
  5. 65
  6. 66
  7. 67

    Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes by Jung, Sungwook

    Published 2023
    “…Immune therapeutics holds great promise in the treatment of type 1 diabetes (T1D). Nonetheless, their progress is hampered by limited efficacy, equipoise, or issues of safety. …”
    Get full text
    Get full text
  8. 68
  9. 69
  10. 70
  11. 71

    Chemical characterization and evaluation of antimicrobial and cutaneous wound healing potentials of gold nanoparticles using Allium saralicum R.M. Fritsch by Hu, X.

    Published 2020
    “…The MIC and MBC of AuNPs against all bacteria were in the ranges 1–4 mg/ml and 2–8 mg/ml, respectively. The MIC and MFC of AuNPs against all fungi were in the ranges 1–4 mg/ml and 2–4 mg/ml, respectively. …”
    Get full text
    Get full text
    Get full text
  12. 72
  13. 73

    Dietary L-carnitine and vitamin-E; a strategy to combat ochratoxin-A induced immunosuppression by Bhatti S.A.

    Published 2018
    “…The dietary addition of OA alone suppressed the humoral immune responses, however, the exposure of birds to 1.0 mg/kg OA in the presence of LC and/or VE showed a significant reduction in OA induced immunotoxicity. …”
    Get full text
    Get full text
  14. 74
  15. 75

    Evaluation of antibody response in symptomatic and asymptomatic covid-19 patients and diagnostic assessment of new IgM/IgG elisa kits by Al-Jighefee, Hadeel T.

    Published 2021
    “…The sensitivity of all IgM kits gradually decreased with time, ranging from 48.7% (EDI)–66.4% (Lionex) at ≤14 days, 29.1% (NovaLisa)–61.8% (Lionex) at 14–30 days, and 6.0% (AnshLabs)–47.9% (Lionex) at >30 days. …”
    Get full text
    Get full text
    Get full text
  16. 76
  17. 77
  18. 78
  19. 79
  20. 80